MiniMed Group (NASDAQ:MMED) Research Coverage Started at Truist Financial

Truist Financial assumed coverage on shares of MiniMed Group (NASDAQ:MMED) in a research note released on Thursday, MarketBeat.com reports. The firm issued a buy rating and a $29.00 price objective on the stock.

A number of other equities research analysts have also commented on the stock. Morgan Stanley upped their price target on shares of MiniMed Group from $19.00 to $21.00 and gave the company an “overweight” rating in a report on Thursday, September 3rd. Bank of America raised their price target on shares of MiniMed Group from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Wednesday, September 2nd. UBS Group boosted their price objective on shares of MiniMed Group from $25.00 to $28.00 and gave the company a “buy” rating in a research report on Wednesday, September 2nd. Weiss Ratings raised shares of MiniMed Group from a “sell (d-)” rating to a “sell (d)” rating in a research note on Wednesday, September 9th. Finally, Wells Fargo & Company increased their target price on shares of MiniMed Group from $22.00 to $26.00 and gave the stock an “overweight” rating in a report on Wednesday, September 2nd. Fourteen investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, MiniMed Group has an average rating of “Moderate Buy” and a consensus price target of $24.14.

MiniMed Group Stock Performance

Shares of MMED stock opened at $19.98 on Thursday. The company has a market capitalization of $5.62 billion and a P/E ratio of -29.38. MiniMed Group has a fifty-two week low of $10.65 and a fifty-two week high of $24.43. The stock has a 50 day moving average price of $20.14 and a two-hundred day moving average price of $16.23.

Institutional Trading of MiniMed Group

Several large investors have recently bought and sold shares of the company. State Street Corp purchased a new stake in MiniMed Group in the second quarter worth $6,029,000. The Manufacturers Life Insurance Company purchased a new position in MiniMed Group during the second quarter valued at $185,000. WINTON GROUP Ltd bought a new stake in shares of MiniMed Group during the 2nd quarter valued at $273,000. Engineers Gate Manager LP purchased a new stake in shares of MiniMed Group in the 2nd quarter worth about $513,000. Finally, Squarepoint Ops LLC purchased a new stake in shares of MiniMed Group in the 2nd quarter worth about $403,000.

MiniMed Group Company Profile

We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.